✦ LIBER ✦

The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis

✍ Scribed by Kawalec, Paweł ;Mikrut, Alicja ;Łopuch, Sylwia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longer term safety of dipeptidyl peptida

✍ K. Gooßen; S. Gräber 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

Efficacy and safety of dipeptidyl peptid

✍ Wu, D.; Li, L.; Liu, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Efficacy and Safety of the Dipeptidyl Pe

✍ Charbonnel, B.; Karasik, A.; Liu, J.; Wu, M.; Meininger, G. 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 148 KB

Efficacy and safety of the dipeptidyl pe

✍ Rhee, E. J.; Lee, W. Y.; Min, K. W.; Shivane, V. K.; Sosale, A. R.; Jang, H. C.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Serum level of soluble CD26/dipeptidyl p

✍ Yoshimasa Aso; Noriyuki Ozeki; Tomoko Terasawa; Rika Naruse; Kenji Hara; Mariko 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Efficacy and safety of the dipeptidyl pe

✍ K. Hermansen; M. Kipnes; E. Luo; D. Fanurik; H. Khatami; P. Stein; Sitagliptin S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB